Detail page

Knowledge Web

Person

Salah-Eddin al- Batran

Internist

Name	Salah-Eddin al- Batran
Place	Frankfurt am Main (Wirkungsort) Deutschland
Academic degree	Prof. Dr. med.
Profession	Internist (characteristic profession) Onkologe Hämatologie Palliativmedizin Schmerztherapie
Variant	Salah E. Al-Batran Salah-Eddin Al-Batran S.-E. Al-Batran S.-E. al- Batran Salah E. al- Batran
Related	Krankenhaus Nordwest
Further information	Diss. Medizinische Fakultät an der Universität München (1996); Habil.-Schr. Fachbereich Medizin (Fach Innere Medizin) an der Universität Frankfurt am Main (2009); Sprecher / Leitgruppe, Arbeitsgruppe Ösophagus-/Magen-Karzinome, UCT - Universitäres Centrum für Tumorerkrankungen Frankfurt
Source	Homepage: http://www.krankenhaus-nordwest.de/kliniken-und-medizinische-einrichtungen/institut-fuer-klinisch-onkologische-forschung/aerztlicher-direktor-prof-dr-med-salah-eddin-al-batran.html (28.06.2016)
Record type	Person
GND-Identifier	114597359
Record ID	114597359
Involved in show all Tumorheterogenität therapierelevanter Biomarker am metastasierten Adenokarzinom des Magen und ösophagogastralen Überganges Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial Der Einfluss des Naturstoffs Curcumin auf das Wachstum und Proliferation von Prostatakarzinomzellen in vitro German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer Wie Checkpoint-Inhibitoren die Therapielandschaft verändern : Immunonkologie bei gastrointestinalen Tumoren Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO Expertise Allgemein- und Viszeralchirurgie - Oberer Gastrointestinaltrakt RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial HER2 testing in gastric cancer: results of a German expert meeting Therapiekonzepte beim metastasierten Magenkarzinom Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program Nab-Paclitaxel : ein neuer Standard in der Therapie des metastasierten Pankreaskarzinoms Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus : a randomized, placebo-controlled phase II AIO trial with serum biomarker program Reply to the Letter to the Editor Biologie und zielgerichtete Therapie des Magenkarzinoms Ramucirumab : neue Behandlungsoption in der Zweitlinientherapie des fortgeschrittenen Magenkarzinoms The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing Pharmacogenetics of Extraordinary Responses to 5-FU/Cisplatin Chemotherapy in Advanced Gastric Cancer – Report of 2 Cases New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer Cancer Patients and the Internet: A Survey of the ‘Quality of Life’ Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie Population-Based Patterns of Care in the First-Line Treatment of Patients with Advanced Esophagogastric Adenocarcinoma in Germany Best practice in gastric cancer and adenocarcinoma of the esophagogastric junction : with 33 tables and 14 therapy protocols Praxis in der Therapie des ösophagogastralen Adenokarzinoms : mit 26 Tabellen sowie 13 Therapieprotokollen Therapiealgorithmen Onkologie Praxis in der Therapie des ösophagogastralen Adenokarzinoms : mit 13 Tabellen sowie 12 Therapieprotokollen Optimierung der Systemtherapie beim fortgeschrittenen Magenkarzinom Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas Immunzytochemischer Nachweis der Serinproteinase Cathepsin G in normalem Knochenmark sowie bei akuten Leukämien : ein Vergleich mit der Myeloperoxidase

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Salah-Eddin al- Batran

Tumorheterogenität therapierelevanter Biomarker am metastasierten Adenokarzinom des Magen und ösophagogastralen Überganges

Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial

Der Einfluss des Naturstoffs Curcumin auf das Wachstum und Proliferation von Prostatakarzinomzellen in vitro

German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer

Wie Checkpoint-Inhibitoren die Therapielandschaft verändern : Immunonkologie bei gastrointestinalen Tumoren

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

Expertise Allgemein- und Viszeralchirurgie - Oberer Gastrointestinaltrakt

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma

Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

HER2 testing in gastric cancer: results of a German expert meeting

Therapiekonzepte beim metastasierten Magenkarzinom

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program

Nab-Paclitaxel : ein neuer Standard in der Therapie des metastasierten Pankreaskarzinoms

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus : a randomized, placebo-controlled phase II AIO trial with serum biomarker program

Reply to the Letter to the Editor

Biologie und zielgerichtete Therapie des Magenkarzinoms

Ramucirumab : neue Behandlungsoption in der Zweitlinientherapie des fortgeschrittenen Magenkarzinoms

The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing

Pharmacogenetics of Extraordinary Responses to 5-FU/Cisplatin Chemotherapy in Advanced Gastric Cancer – Report of 2 Cases

New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

Cancer Patients and the Internet: A Survey of the ‘Quality of Life’ Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie

Population-Based Patterns of Care in the First-Line Treatment of Patients with Advanced Esophagogastric Adenocarcinoma in Germany

Best practice in gastric cancer and adenocarcinoma of the esophagogastric junction : with 33 tables and 14 therapy protocols

Praxis in der Therapie des ösophagogastralen Adenokarzinoms : mit 26 Tabellen sowie 13 Therapieprotokollen

Therapiealgorithmen Onkologie

Praxis in der Therapie des ösophagogastralen Adenokarzinoms : mit 13 Tabellen sowie 12 Therapieprotokollen

Optimierung der Systemtherapie beim fortgeschrittenen Magenkarzinom

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

Immunzytochemischer Nachweis der Serinproteinase Cathepsin G in normalem Knochenmark sowie bei akuten Leukämien : ein Vergleich mit der Myeloperoxidase